Daxyclot-2.5 contains Rivaroxaban (2.5 mg) an oral anticoagulant used to prevent and treat blood clots in various medical conditions including deep vein thrombosis (DVT) and pulmonary embolism (PE). By inhibiting Factor Xa Daxyclot-2.5 effectively reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. This low-dose option is ideal for individuals needing precise anticoagulation therapy to maintain cardiovascular health.
Reviews
There are no reviews yet.